US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,481.82

+11.070.75%

Number of Gainers:15

Number of Losers:3

Number of Flat:1

PE:- -

High:1,483.59

Open:1,470.85

Low:1,469.38

Close:1,470.74

Volume:57.49M

Turnover:1.56B

Market Cap:1.22T

Float Cap:1.20T

Loading ...

Co-Diagnostics Prices $3.8 Million Direct Offering of Common Stock

MT Newswires Live

Co-Diagnostics prices 9.62M shares at 40c in registered direct offering

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

AstraZeneca (AZN.US) Files Application for Triple Asthma Therapy "Breztri" in China

Johnson & Johnson's Experimental Psoriasis Drug Shows Promise Over Bristol-Myers Squibb Treatment

Icotrokinra Shows Superiority to Deucravacitinib in First Reported Head-to-Head Trials Reinforcing Promise of Novel Targeted Oral Peptide for Treatment of Plaque Psoriasis

THOMSON REUTERS

Co-Diagnostics Is Maintained at Buy by D. Boral Capital

AstraZeneca Says Phase 3 Trial of Fasenra in COPD Fails to Meet Primary Endpoint

MT Newswires Live

AstraZeneca's (AZN.US) Star Asthma Drug Fasenra Fails to Meet Primary Endpoint in Late-Stage COPD Study

Moderna Inc. Stock Rises 4.0%, Outperforms Peers

Moderna, Inc. Surges 4.8% in Late Trading

Moderna Stock Is Moving Higher Tuesday: Here's Why

Benzinga_recent_news

Co-Diagnostics Signs MOU for Middle East Expansion of Point-of-Care Platform

MT Newswires Live

Co-Diagnostics signs MoU with partner in Kingdom of Saudi Arabia

Co-Diagnostics, Inc. Signs Strategic Mou With Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ Pcr Platform to Middle East

THOMSON REUTERS

AstraZeneca (AZN) Gets a Buy from Goldman Sachs

Ocugen Signs Exclusive License Agreement with Kwangdong

Moderna Says New Covid-19 Vaccine Generates Strong Response Against Variant

3 Things You Need to Know If You Buy Pfizer Today

3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1481.8126,"timestamp":1758125200000,"preClose":1470.7393,"halted":0,"volume":57485319,"delay":0,"changeRate":0.007529,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":11.073364,"latestTime":"09-17 12:06:40 EDT","open":1470.8473,"high":1483.5944,"low":1469.3794,"amount":1562002143.669959,"amplitude":0.009665,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.836858,"peRate":20.735352,"turnoverRate":0.003742,"increases":15,"decrements":3,"flats":1,"marketCap":1215715251106.5,"floatMarketCap":1196355069226.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1483.5944,"amplitude":0.009665,"preClose":1470.7393,"low":1469.3794,"pbRate":"3.836858","latestPrice":1481.8151,"volume":57487393,"delay":0,"open":1470.8473,"prevYearClose":1274.8187,"prevWeekClose":1488.5051,"prevMonthClose":1489.44,"prevQuarterClose":1377.5769,"fiveDayClose":1484.1697,"twentyDayClose":1501.6229,"sixtyDayClose":1360.6882,"secType":"PLATE","market":"US","turnoverRate":0.003743,"peRate":20.735352,"marketCap":1215716480418.5,"floatMarketCap":1196355568906.5,"timestamp":1758125204250,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":15,"down":3,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568494412","title":"Co-Diagnostics Prices $3.8 Million Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2568494412","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568494412?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:03","pubTimestamp":1758117812,"startTime":"0","endTime":"0","summary":"Co-Diagnostics  said Wednesday it priced a registered direct offering of about 9.6 million common shares at $0.40 per share for gross proceeds of about $3.8 million.The company said it plans to use proceeds from the offering, which is expected to close on or about Thursday, for working capital and general corporate purposes.Shares of Co-Diagnostics were down 29% in recent trading Wednesday.Price: 0.45, Change: -0.19, Percent Change: -29.01","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2568494168","title":"Co-Diagnostics prices 9.62M shares at 40c in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2568494168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568494168?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:50","pubTimestamp":1758117011,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) announced that it has entered into a securities purchase agreement with several institutional investors for the purchase and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-prices-9-62m-shares-at-40c-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-prices-9-62m-shares-at-40c-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2568049482","title":"Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2568049482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568049482?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:47","pubTimestamp":1758116835,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA5PP4F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"1189302356","title":"AstraZeneca (AZN.US) Files Application for Triple Asthma Therapy \"Breztri\" in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1189302356","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189302356?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:02","pubTimestamp":1758114159,"startTime":"0","endTime":"0","summary":"On September 17, the CDE website showed that AstraZeneca PLC (AZN.US) has submitted an application for a new indication for its budesonide/glycopyrronium/formoterol inhalation aerosol (brand name:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU0109394709.USD","LU2417539215.USD","LU2236285917.USD","LU0889565916.HKD","AZN","BK4585","LU2456880835.USD","BK4007","LU0320765992.SGD","LU2462157665.USD","LU1829250122.USD","BK4588"],"gpt_icon":0},{"id":"1186792971","title":"Johnson & Johnson's Experimental Psoriasis Drug Shows Promise Over Bristol-Myers Squibb Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1186792971","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186792971?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:00","pubTimestamp":1758114031,"startTime":"0","endTime":"0","summary":"Johnson & Johnson shares gained modestly in Wednesday pre-market trading following reports that the company's experimental psoriasis treatment demonstrates potential advantages over Bristol-Myers...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU1894683264.USD","BMY","LU0345770308.USD","LU2125154778.USD","LU0345769631.USD","LU1674673691.USD","LU2505996509.AUD","LU2242646821.SGD","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","LU1506573853.SGD","LU1674673428.USD","LU1066053197.SGD","BK4532","IE00BDGV0183.EUR","LU1291159041.SGD","JNJ","LU0306806265.USD","LU0321505868.SGD","LU0795875086.SGD","LU1868836757.USD","LU1066051811.HKD","IE00BBT3K403.USD","BK4592","LU2133065610.SGD","LU0985481810.HKD","LU0868494617.USD","LU1261432733.SGD","BK4568","LU0203347892.USD","LU0320765646.SGD","LU1894683348.USD","LU0058720904.USD","SG9999001440.SGD","LU1280957306.USD","LU1670710661.SGD","LU1868837300.USD","LU0795875169.SGD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU1032955483.USD","LU2430703251.USD","IE00BJJMRZ35.SGD","LU1732800096.USD","LU2129689605.HKD","LU2242652126.USD","LU0061475181.USD","LU0321505439.SGD","SG9999002232.USD","LU0122379950.USD","LU2471134523.USD","LU0098860793.USD","LU1093756168.USD","BK4585","LU1718418525.SGD","LU1032466523.USD","IE00B7SZLL34.SGD","IE00BLSP4239.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU1868836591.USD","LU0466842654.USD","BK4007","LU1244550221.USD","IE00BLSP4452.SGD","LU1196500208.SGD","LU1430594728.SGD","LU2750360997.AUD","LU0096364046.USD","LU0640476718.USD","LU1323610961.USD","BK4534","LU1732799900.SGD","IE00B4R5TH58.HKD","LU0237698245.USD","IE00BGHQF631.EUR","IE00B3PB1722.GBP","BK4550","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU2471134952.CNY","IE0009355771.USD","LU2471134879.HKD","LU2505996681.GBP","LU1989771016.USD","LU1670710588.SGD","LU0203345920.USD","LU1057294990.SGD","LU2347655156.SGD","IE00B3T34201.USD","LU0432979614.USD","LU0345770993.USD","LU0889566641.SGD","LU0289739699.SGD","IE00B42XCP33.USD","LU1023059063.AUD","LU2430703095.HKD","LU1778281490.HKD","LU1066051225.USD","LU1244550577.SGD","LU2129689431.USD","LU1868837136.USD","LU2430703178.SGD","LU0306807586.USD","LU1074936037.SGD","BK4581","LU0267386448.USD","LU1066051498.USD","LU1244550494.USD","IE00BVYPNW00.USD","LU1571399168.USD","LU0234570918.USD","LU1162221912.USD","LU1935042991.SGD","LU2592432038.USD","LU0070217475.USD","LU0456855351.SGD","LU0912757837.SGD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU0345769128.USD","IE00BVYPNV92.GBP","BK4559","LU1670711123.USD","LU1929549753.HKD","LU2468319806.SGD","LU1267930813.SGD","LU2471134796.USD","LU2750360641.GBP","LU1061106388.HKD","BK4588","LU1221951129.SGD","LU2129689514.USD","LU0225284248.USD","LU0234572021.USD","BK4533","LU1914381329.SGD","LU1670711040.USD","BK4504","IE00B19Z3581.USD","LU2089984988.USD","IE0002141913.USD","LU0985320562.USD","LU0225771236.USD","LU2125154935.USD","LU1585245621.USD","LU1868836914.USD","LU2360032135.SGD","IE0002270589.USD","LU2112291526.USD","IE0034235303.USD","LU0792757196.USD","LU1059921491.USD","IE00B1BXHZ80.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1221951046.USD"],"gpt_icon":0},{"id":"2568495352","title":"Icotrokinra Shows Superiority to Deucravacitinib in First Reported Head-to-Head Trials Reinforcing Promise of Novel Targeted Oral Peptide for Treatment of Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2568495352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568495352?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:00","pubTimestamp":1758110412,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1221951129.SGD","LU1032466523.USD","LU1261432733.SGD","LU2430703095.HKD","LU2471134952.CNY","LU2471134523.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU2505996509.AUD","LU2471134879.HKD","IE00BBT3K403.USD","LU2468319806.SGD","BK4568","LU2112291526.USD","IE00B3T34201.USD","JNJ","BK4534","LU1066051498.USD","LU1244550577.SGD","LU1732799900.SGD","BK4592","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU1032955483.USD","LU1057294990.SGD","LU1244550221.USD","LU2505996681.GBP","LU1221951046.USD","LU0792757196.USD","LU0345769128.USD","LU1061106388.HKD","LU1066051225.USD","LU0345769631.USD","LU1023059063.AUD","IE00BN8TJ469.HKD","LU1066051811.HKD","IE00BJT1NW94.SGD","BK4585","LU0345770308.USD","LU2129689605.HKD","LU0098860793.USD","IE00B4R5TH58.HKD","BK4504","LU0466842654.USD","LU2592432038.USD","IE0009355771.USD","LU0320765646.SGD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2568797493","title":"Co-Diagnostics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2568797493","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568797493?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:54","pubTimestamp":1758110040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CODX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 17, 2025 07:54 ET (11:54 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2568249332","title":"AstraZeneca Says Phase 3 Trial of Fasenra in COPD Fails to Meet Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2568249332","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568249332?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:36","pubTimestamp":1758108995,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Wednesday that a phase 3 trial of its asthma treatment Fasenra in patients with chronic obstructive pulmonary disease, or COPD, did not meet the primary endpoint despite showing numerical improvement.The company said Fasenra's safety and tolerability in the trial was consistent with the known profile of the drug, which is currently approved as an add-on maintenance medicine for severe eosinophilic asthma.AstraZeneca said it will analyze the full data set from the trial and share the findings with the scientific community.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2456880835.USD","LU0109394709.USD","AZN","LU1829250122.USD","BK4585","LU2417539215.USD","BK4007","LU0320765992.SGD","LU2236285917.USD","BK4588","LU0889565916.HKD","LU2462157665.USD","BK4568"],"gpt_icon":0},{"id":"1130898591","title":"AstraZeneca's (AZN.US) Star Asthma Drug Fasenra Fails to Meet Primary Endpoint in Late-Stage COPD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1130898591","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130898591?lang=en_us&edition=fundamental","pubTime":"2025-09-17 16:58","pubTimestamp":1758099517,"startTime":"0","endTime":"0","summary":"AstraZeneca PLC (AZN.US) announced on Wednesday that its asthma medication Fasenra failed to control the rate of acute exacerbations in a late-stage study targeting patients with chronic obstructive...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4007","LU0889565916.HKD","AZN","LU0109394709.USD","LU2417539215.USD","LU2462157665.USD","BK4585","BK4588","LU2236285917.USD","LU2456880835.USD","LU1829250122.USD","BK4568"],"gpt_icon":0},{"id":"2568355004","title":"Moderna Inc. Stock Rises 4.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2568355004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568355004?lang=en_us&edition=fundamental","pubTime":"2025-09-17 04:34","pubTimestamp":1758054840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 4.0% to $24.84 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 22,333.96 and Dow Jones Industrial Average falling 0.3% to 45,757.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 67.0% below its 52-week high of $75.37, which the company achieved on September 17th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.5% to $176.46, Pfizer Inc. fell 0.3% to $23.90, and Gilead Sciences Inc. fell 1.49% to $110.86.Trading volume totaled 15.6 million, compared to the 50-day average of 9.9 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0234572021.USD","LU0321505439.SGD","BK4501","LU0306807586.USD","SGXZ57979304.SGD","BK4007","SG9999003800.SGD","MRNA","LU0225284248.USD","SG9999013999.USD","IE00B19Z3581.USD","BK4548","LU0306806265.USD","BK4568","IE0002270589.USD","LU1066051498.USD","IE000M9KFDE8.USD","SG9999002232.USD","LU0225771236.USD","IE00B19Z3B42.SGD","BK4585","LU0985481810.HKD","BK4139","LU1066053197.SGD","SG9999002224.SGD","LU0058720904.USD","BK4533","IE00BLSP4452.SGD","BK4532","LU0122379950.USD","SG9999011175.SGD","LU0321505868.SGD","SG9999001176.SGD","BK4550","LU1057294990.SGD","LU1023059063.AUD","BK4599","BK4581","BK4551","BK4588","LU0456855351.SGD","LU1894683348.USD","LU0170899867.USD","LU1883839398.USD","IE00BBT3K403.USD","BK4534","LU1894683264.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"1134215863","title":"Moderna, Inc. Surges 4.8% in Late Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1134215863","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134215863?lang=en_us&edition=fundamental","pubTime":"2025-09-17 03:51","pubTimestamp":1758052271,"startTime":"0","endTime":"0","summary":"S&P 500 component Moderna, Inc. (MRNA) climbed 4.8%, extending its rebound momentum from Monday's session. The vaccine sector broadly declined last Friday after Trump administration health officials...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4532","BK4548","BK4139","BK4501","MRNA","CDC","BK4551","BK4534","BK4568","BK4585","BK4588"],"gpt_icon":0},{"id":"2568433396","title":"Moderna Stock Is Moving Higher Tuesday: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2568433396","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568433396?lang=en_us&edition=fundamental","pubTime":"2025-09-17 03:41","pubTimestamp":1758051660,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (NASDAQ:MRNA) shares are up nearly 5% on Tuesday after the company announced positive preliminary immunogenicity data for its 2025-2026 Spikevax formula, which targets the new LP.8.1 variant of COVID-19.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/16/Augsburg--Bavaria--Germany---March-21--2.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/16/Augsburg--Bavaria--Germany---March-21--2.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/09/47702433/moderna-stock-is-moving-higher-tuesday-heres-why","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/09/47702433/moderna-stock-is-moving-higher-tuesday-heres-why","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BNTX","BK4548","BK4568","BK4551","BK4535","BK4585","BK4588","CDC","BK4139"],"gpt_icon":0},{"id":"2567485705","title":"Co-Diagnostics Signs MOU for Middle East Expansion of Point-of-Care Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2567485705","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567485705?lang=en_us&edition=fundamental","pubTime":"2025-09-16 22:18","pubTimestamp":1758032326,"startTime":"0","endTime":"0","summary":"Co-Diagnostics  said Tuesday it signed a memorandum of understanding with an undisclosed regional manufacturing and distribution company in Saudi Arabia to explore a joint venture with a license to develop, manufacture and sell its Co-Dx technology in the Middle East and North Africa,The agreement includes the company's upcoming Co-Dx PCR point-of-care platform.The Saudi partner will contribute local operational support, infrastructure, personnel and regulatory expertise, and the joint venture may benefit from applicable government incentives, Co-Diagnostics said.Price: 0.36, Change: +0.01, Percent Change: +2.55","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2567557483","title":"Co-Diagnostics signs MoU with partner in Kingdom of Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2567557483","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567557483?lang=en_us&edition=fundamental","pubTime":"2025-09-16 21:35","pubTimestamp":1758029714,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) announced that it has signed a strategic Memorandum of Understanding with a regional manufacturing and distribution company l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-signs-mou-with-partner-in-kingdom-of-saudi-arabia-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-signs-mou-with-partner-in-kingdom-of-saudi-arabia-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2567880234","title":"Co-Diagnostics, Inc. Signs Strategic Mou With Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ Pcr Platform to Middle East","url":"https://stock-news.laohu8.com/highlight/detail?id=2567880234","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567880234?lang=en_us&edition=fundamental","pubTime":"2025-09-16 21:30","pubTimestamp":1758029403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nTUABPNCWJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2567101825","title":"AstraZeneca (AZN) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2567101825","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567101825?lang=en_us&edition=fundamental","pubTime":"2025-09-16 18:56","pubTimestamp":1758020182,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca today and set a price target of £150.13. The company’s shares opened toda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443622.USD","LU1668664300.SGD","LU2462157665.USD","BK4533","LU0742534661.SGD","LU1868837136.USD","LU2417539215.USD","LU1894683348.USD","IE0004091025.USD","LU2237443465.HKD","LU2750360641.GBP","IE00BSNM7G36.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU1868836757.USD","BK4568","LU1804176565.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","AZN","LU2750360997.AUD","IE0034235188.USD","LU2265009873.SGD","LU0106831901.USD","BK4552","LU1791807156.HKD","LU1868836914.USD","LU2237438978.USD","IE0004086264.USD","LU2237443382.USD","BK4007","BK4504","BK4585","LU2471134879.HKD","BK4550","LU0251142724.SGD","BK4127","LU0048573561.USD","LU1868836591.USD","LU0889565916.HKD","LU0109394709.USD","LU0061475181.USD","BK4516","LU2456880835.USD","LU0320765992.SGD","LU2237443978.SGD","LU2471134523.USD","LU0096364046.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2567210996","title":"Ocugen Signs Exclusive License Agreement with Kwangdong","url":"https://stock-news.laohu8.com/highlight/detail?id=2567210996","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567210996?lang=en_us&edition=fundamental","pubTime":"2025-09-16 18:38","pubTimestamp":1758019133,"startTime":"0","endTime":"0","summary":"The latest update is out from Ocugen ( ($OCGN) ). On September 11, 2025, Ocugen, Inc. entered into an Exclusive License Agreement with Kwangdong Ph...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocugen-signs-exclusive-license-agreement-with-kwangdong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocugen-signs-exclusive-license-agreement-with-kwangdong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCGN","BK4563","BK4568","BK4139"],"gpt_icon":0},{"id":"2567093621","title":"Moderna Says New Covid-19 Vaccine Generates Strong Response Against Variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2567093621","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567093621?lang=en_us&edition=fundamental","pubTime":"2025-09-16 18:30","pubTimestamp":1758018600,"startTime":"0","endTime":"0","summary":"Moderna said the 2025-2026 formula of its Covid-19 vaccine produced a strong immune response against the dominant LP.8.1 variant.The company said a preliminary analysis from a phase four clinical trial showed the new formula of its Spikevax vaccine generated an eight-fold increase in LP.8.1-neutralizing antibodies.No new safety concerns of the vaccine were identified.Spikevax is approved for individuals six months through 64 years of age with at least one underlying condition that puts them at higher risk for Covid-19, and all adults 65 years and older.The company said CDC data from U.S. wastewater shows Covid-19 activity is high, with LP.8.1 and its familial strains continuing to dominate.Earlier this month, Pfizer and BioNTech said the updated formula of their Covid-19 vaccine generated a strong response against the variant.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0456855351.SGD","LU0058720904.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU0122379950.USD","LU0234572021.USD","SG9999013999.USD","SG9999011175.SGD","SG9999002224.SGD","SG9999002232.USD","IE000M9KFDE8.USD","BK4139","LU0306807586.USD","IE00BLSP4452.SGD","MRNA","BK4533","BK4007","IE0002270589.USD","LU0225771236.USD","SG9999001176.USD","BK4588","BNTX","LU0868494617.USD","LU1883839398.USD","LU1894683348.USD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","LU0321505439.SGD","SG9999001176.SGD","LU1057294990.SGD","LU0170899867.USD","BK4501","LU1066051498.USD","LU1894683264.USD","BK4535","IE00B19Z3581.USD","BK4568","SG9999003800.SGD","IE00BLSP4239.USD","BK4534","BK4585","BK4581","LU0225284248.USD","BK4550","BK4532","BK4548","BK4551"],"gpt_icon":1},{"id":"2567317004","title":"3 Things You Need to Know If You Buy Pfizer Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2567317004","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567317004?lang=en_us&edition=fundamental","pubTime":"2025-09-16 16:40","pubTimestamp":1758012000,"startTime":"0","endTime":"0","summary":"Pfizer has an attractive 7.2% dividend yield, but this healthcare giant might be a riskier dividend stock than you want to own.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833607%2F22_10_31-a-doctor-talking-to-a-parent-and-a-child-in-a-medical-setting-_mf-dload.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833607%2F22_10_31-a-doctor-talking-to-a-parent-and-a-child-in-a-medical-setting-_mf-dload.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/09/16/3-things-you-need-to-know-if-you-buy-pfizer-today/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/09/16/3-things-you-need-to-know-if-you-buy-pfizer-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0289739699.SGD","LU0985481810.HKD","LU1023059063.AUD","BK4592","IE0002270589.USD","BK4588","LU0170899867.USD","LU0058720904.USD","BK4533","LU0225771236.USD","PFE","IE00BLSP4452.SGD","LU0234572021.USD","LU0225284248.USD","BK4550","BK4568","BK4534","IE00B19Z3B42.SGD","LU0306806265.USD","SG9999001176.USD","LU0321505868.SGD","SGXZ57979304.SGD","LU1066053197.SGD","LU0122379950.USD","BK4599","LU1066051498.USD","SG9999011175.SGD","IE00BBT3K403.USD","IE000M9KFDE8.USD","BK4581","BK4585","BK4007","LU0456855351.SGD","LU1894683348.USD","SG9999001176.SGD","SG9999003800.SGD","IE00B19Z3581.USD","LU0306807586.USD","IE00BLSP4239.USD","LU1057294990.SGD","SG9999002232.USD","LU1894683264.USD","LU0868494617.USD","LU1883839398.USD","LU0321505439.SGD","SG9999013999.USD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2567170888","title":"3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2567170888","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567170888?lang=en_us&edition=fundamental","pubTime":"2025-09-16 16:22","pubTimestamp":1758010920,"startTime":"0","endTime":"0","summary":"A good stock is an even better buy when it's on sale, even if your primary goal is immediate and reliable income.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833283%2Fthinking-man-at-a-desk-reviewing-paperwork.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833283%2Fthinking-man-at-a-desk-reviewing-paperwork.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/09/16/magnificent-sp-500-dividend-stocks-down-buy-hold/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/09/16/magnificent-sp-500-dividend-stocks-down-buy-hold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4592","BK4534","LU1057294990.SGD",".SPX","LU0306806265.USD","LU0058720904.USD","BK4588","IE00B19Z3581.USD","LU1023059063.AUD","IE000M9KFDE8.USD","SPY","IE00BLSP4239.USD","UPRO","SG9999002224.SGD","SDS","SG9999002232.USD","VOO","OEF","BK4568","ESmain","BK4599","LU0225284248.USD","BK4550","LU0122379950.USD","LU0234572021.USD","IE0002270589.USD","LU0306807586.USD","LU0321505439.SGD","LU0868494617.USD","SPXU","BK4559","SGXZ57979304.SGD","SH","IVV","IE00B19Z3B42.SGD","BK4504","LU0321505868.SGD","LU1894683348.USD","OXY","SG9999001176.USD","SG9999011175.SGD","LU0985481810.HKD","LU0289739699.SGD","IE00BBT3K403.USD","OEX","LU1066051498.USD","SSO","MESmain","BK4007"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":197,"code":"91000000","status":"200"}]}}